Gross Harald
Institute for Pharmaceutical Biology, Nussallee 6, 53115, Bonn, Germany.
Appl Microbiol Biotechnol. 2007 May;75(2):267-77. doi: 10.1007/s00253-007-0900-5. Epub 2007 Mar 6.
The recent increase and availability of whole genome sequences have revised our view of the metabolic capabilities of microorganisms. From these data, a large number of orphan biosynthesis pathways have been identified by bio-informatics. Orphan biosynthetic pathways are gene clusters for which the encoded natural product is unknown. It is worthy to note that the number of orphan pathways coding for putative natural products outnumbers by far the number of currently known metabolites for a given organism. Whilst Streptomyces coelicolor was known to produce only 4 secondary metabolites, the genome analysis revealed 18 additional orphan biosynthetic pathways. It is intriguing to note that this is not a particular case because analysis of other microbial genomes originating from myxobacteria, cyanobacteria and filamentous fungi showed the presence of a comparable or even larger number of orphan pathways. The discovery of these numerous pathways represents a treasure trove, which is likely to grow exponentially in the future, uncovering many novel and possibly bio-active compounds. The few natural products that have been correlated with their orphan pathway are merely the tip of the iceberg, whilst plenty of metabolites await discovery. The recent strategies and methods to access these promising hidden natural products are discussed in this review.
全基因组序列最近的增加及其可得性改变了我们对微生物代谢能力的看法。基于这些数据,通过生物信息学已经鉴定出大量的孤儿生物合成途径。孤儿生物合成途径是指那些编码未知天然产物的基因簇。值得注意的是,对于给定的生物体,编码推定天然产物的孤儿途径的数量远远超过目前已知代谢物的数量。虽然已知天蓝色链霉菌仅产生4种次级代谢产物,但基因组分析揭示了另外18条孤儿生物合成途径。有趣的是,这并非个别情况,因为对源自粘细菌、蓝细菌和丝状真菌的其他微生物基因组的分析表明,存在数量相当甚至更多的孤儿途径。这些众多途径的发现代表了一个宝库,未来很可能会呈指数级增长,揭示许多新型且可能具有生物活性的化合物。与它们的孤儿途径相关联的少数天然产物仅仅是冰山一角,还有大量代谢物有待发现。本文综述了最近获取这些有前景的隐藏天然产物的策略和方法。